Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 64NIH 10NETWORK 8INDUSTRY 4OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 39Neoplasms, Plasma Cell 8Lymphoma 8Hematologic Neoplasms 5Recurrence 3Leukemia 3Lymphoma, B-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoglobulin Light-chain Amyloidosis 2Disease Progression 2Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumococcal 1Pneumococcal Infections 1Peripheral Nervous System Diseases 1Neoplasms 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma, Malignant 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Plasma Cell 1Hodgkin Disease 1Heart Neoplasms 1Fractures, Spontaneous 1Febrile Neutropenia 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Monoclonal Gammopathy of Undetermined Significance × Plasma cell × Clear all
NCT07214324 2026-04-23

PNRR-2022-1237

Azienda USL Reggio Emilia - IRCCS

Recruiting
60 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡